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(AV delay hysteresis: AVDH). More recently, new modes of pacing were pro-
posed: MVP™ mode (Managed Ventricular Pacing) Medtronic-USA. The aim
of this study was to evaluate the gain of spontaneous conduction between dif-
ferent generations of AVDH and the MVP™ mode.
Methods: we studied two populations of patients implanted for conduction
disorder (CD) or sinus dysfunction (SD) distributed in three groups. 
Group I : 115 patients implanted with Kappa® series PM (Medtronic-USA)
and first generation AVDH (AVDH, CD : 56%, SD : 44%). 
Group II: 168 patients implanted with Enpulse® series PM (Medtronic-USA)
and 2nd generation AVDH (AVDH+, CD: 52%, SD: 48%). 
Group III: 156 patients implanted with Adapta® series PM (Medtronic-USA)
and the MVP™ mode (CD: 40%, SD: 60%). 
Populations were not different in sex, age and pacing indications. Patients who
presented less than 1% of spontaneous ventricular activity were excluded from
analysis. We compared first the gain in ventricular detection induced by
AVDH vs. AVDH+ and secondly the percentage of ventricular pacing
between AVDH+ and MVP in the two populations (Mood’s median test).
Results: shown in the following table:
Conclusion: AVDH+ results in a decrease in VP in patients without con-
duction disorder but not in patients with conduction disorder. The use of
MVP™ results in a significant decrease of ventricular pacing compared to first
and second generation of AVDH algorithms in both patients with or without
conduction disorder with a high gain in spontaneous AV conduction.
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Methods: The multicenter observational Generation MVP™ study
included 224 patients aged 77 + / - 10 years (men: 53%) implanted for sinus
dysfunction (SD) or brady-tachy syndrome (SBT) (n = 116) or atrio-ventric-
ular block (AVB) (n = 108). Programming function MVP™ has been left to
the discretion of the physician. Percentage of ventricular pacing and per-
centage of patients with paroxystic or persistent atrial arrhythmias was
assessed at 9 months on average according to the indication of pacing and the
state of programming function MVP™. 
Results: Percentage of ventricular pacing at 9 months is significantly lower
for the 2 groups of indication for patients with MVP™ function activated [On]
compared with patients without function MVP™ [Off]. Comparisons groups
were made by the Mood’s median test.  
Percentage of patients with atrial arrhythmias at 9 months was significantly
lower when the MVP™ function is programmed to [On] only in the AVB
group.
Conclusion: In this study in current practice, at 9 months follow-up pro-
gramming function MVP™ is associated with a significant decrease of ven-
tricular pacing for indications of SD-BTS and AV block. Moreover
programming function MVP™ is associated with a significant decrease of per-
centage of patients with atrial arrhythmias for AVB indications.
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Purpose: Right ventricular (RV) apex pacing is associated with LV dys-
synchrony. Alternate RV pacing sites (mid RV septum; the RV outflow tract
(RVOT)) were considered, with no clear benefit. The aim of this study is to
find a reliable method of septal lead placement ant to identify those pacing
sites which provide a better LV electrical activation.
Methods: 50 consecutive patients reffered for  pacemaker implants due to
AV block were included. Patients with history of heart failure or LVEF<50%
at implant were excluded. All patients had RV leads placed in septal position.
RV septum and RVOT were mapped during implant searching for the nar-
rowest paced QRS with an axis as close to normal as possible. Pacing lead
position was evaluated during implant using fluoroscopy (AP and LAO 40º)
and than by 12 lead ECG and echo. Intra LV dyssinchrony was evaluated
during pacing using SPWMD in parasternal short axis view and TDI septal to
lateral t. Paced QRS duration and axis were also recorded. A correlation was
sought between lead position evaluated by Rx and by echo and between paced
QRS duration and axis and LV dyssunchrony.
Results: 92%(46) of the patients had the RV lead in septal position (32 in
mid RV and 14 in RVOT) while 8% (4 pts) had the RV lead on the RVOT
free wall as shown by echo. An anteriorly oriented lead in the left anterior
oblique fluoroscopic projection was specific for free wall position while a pos-
itive QRS in DI in RVOT position was suggestive for free wall position on the
ECG. No correlation was made between paced QRS axis and LV dyssinchron.
A QRS duration of>160 ms was associated with significant LV dyssinchrony
(SPWMD>130 ms and septal to lateral t>70 ms).
Conclusions: RV lead placement on the RV septum can be reliably
achieved using a specialy shaped stilet and LAO projection for confirmation.
A wide paced QRS is correlated with significant intra LV dyssinchrony and
therefore the pacing site with the narrowest QRS should be sought.
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Background: The mechanisms of action of cardiac resynchronisation
therapy (CRT) and the predictive factors to CRT’s effect are not well known.
The mechanical left intra-ventricular dysynchrony (LIVD) has  a important
physiopathological role in severe left ventricular dysfunction with wide QRS.
Several studies compared  LIVD before and just after CRT implant but few
data are available about LIVD in the mid to long term.
 AVDH  AVDH (+)  MVP
 % VP with conduction disorder
Médian 99.7 N.S. 99.7 p < 0.001 15.0
1st , 3rd quart 97.1 - 99.8 66.1 - 100 1.4 - 79.2
 % VP without conduction disorder
Médian 78.5 p < 0.001 25.8 p < 0.001 1.8
1st , 3rd quart 43 - 95.1 6.9 - 72.7 1.3 - 5.6
Indication SD - BTS (n = 116) AVB (n = 108)





Number of pts 19  97 39  69
% VP 79% < 0.001 1% 99% < 0.001 15%
médian
1ier- 3ième Quart 13.5 - 99.6  0.3 - 5.6 99 - 100  0.4 - 75.6
% pts in AA 26% NS 19% 23% < 0.05 6%
January 14th , Friday 2011
